The herpesvirus proteases are an example in which allosteric regulation of an enzyme activity is achieved through the formation of quaternary structure. Here, we report a 1.7 Å resolution structure of Kaposi's sarcoma-associated herpesvirus protease in complex with a hexapeptide transition state analogue that stabilizes the dimeric state of the enzyme. Extended substrate binding sites are induced upon peptide binding. In particular, 104 Å 2 of surface are buried in the newly formed S4 pocket when tyrosine binds at this site. The peptide inhibitor also induces a rearrangement of residues that stabilizes the oxyanion hole and the dimer interface. Concomitant with the structural changes, an increase in catalytic efficiency of the enzyme results upon extended substrate binding. A nearly 20-fold increase in k cat /K M results upon extending the peptide substrate from a tetrapeptide to a hexapeptide exclusively due to a K M effect. This suggests that the mechanism by which herpesvirus proteases achieve their high specificity is by using extended substrates to modulate both the structure and activity of the enzyme.
Introduction
The herpesvirus family encodes a protease whose activity is regulated by a unique oligomerization dependent allosteric mechanism. [1] [2] [3] [4] [5] [6] The inactive monomeric protease is expressed fused to an assembly protein in the cytosol and subsequently imported into the nucleus. [7] [8] [9] [10] [11] Concentration dependent dimerization within the nuclear localized immature capsids activates the protease. 1, 2, 12 The active protease is released from the assembly protein by auto-processing at the release (R) site. 10, 11, [13] [14] [15] Protease processing of the assembly protein, a major scaffold protein, at the maturation (M) site leads to capsid maturation and virion formation. 11, 14, 16, 17 Recent studies on the Kaposi's sarcoma-associated herpesvirus (KSHV) protease suggest an induced structure upon dimerization as a concentration dependent activation of the enzyme. [4] [5] [6] This induced structure model differs from canonical induced fit in that the free energy of subunit dimerization is used to organize the active site and provide a unique mechanism for activating proteolytic activity. In this model, dimerization induced folding of helix 5, the major contributor to the dimer interface, and helix 6, which is crucial for stabilization of the oxyanion hole, stabilizes elements that are essential for catalytic activity.
Similarly, structural studies of the related human cytomegalovirus (HCMV) protease, 3 reveal loss of catalytic activity of a dimer interface mutant due to disordering of both the C-terminal helix G and the L10 loop (H6 and L10 in KSHV protease) that support the catalytic machinery. In addition, the ordering of these structural elements, in the HCMV protease variant can be induced by binding of a peptidomimetic inhibitor. Finally, upon binding of a peptide phosphonate inhibitor at the active site of KSHV protease, the equilibrium is shifted toward the dimeric enzyme, suggesting communication between the active site and the dimer interface. 4 We sought to understand how substrate binding and its effect on the disorder-to-order transition could regulate catalytic activity in KSHV protease. To understand the structural basis of the stabilized oligomer state we have used the hexapeptide diphenylphosphonate transition state analog previously shown to dramatically shift the equilibrium to the dimeric form of the enzyme. We have crystallized KSHV protease bound to this inhibitor and determined the structure of the complex. The structure elucidates atomic details of substrate binding pockets, which are composed of loops previously disordered in the apo structure of KSHV protease. In addition, an induced fit to the extended substrate binding pockets of the protease is revealed, which is most pronounced at S4. The structural evidence for protease extended substrate specificity that leads to enhanced catalytic efficiency is revealed. This suggests that substrate binding could provide another level of regulation of protease activity in this enzyme beyond the initial concentration dependent activation mechanism described previously.
Results

Extended substrate binding improves catalytic efficiency
The positional scanning synthetic combinatorial libraries previously used to determine the KSHV non-prime side substrate specificity contained only tetrameric substrates. 4 To determine the extent of the extended substrate specificity for KSHV protease we synthesized five nested sets of substrates with the trimeric tbutyl-Gln-Ala being the shortest and the heptameric Ser-Pro-Val-Tyr-tbutyl-Gln-Ala substrate being the longest. All substrates were acetylated on their N termini and included the fluorogenic reporter group 7-amino-4-carbamoyl-methylcoumarin to monitor enzyme activity spectroscopically. The amino acid sequence of the tri-, tetra-, penta-and hexameric substrates corresponds to the sequence of the hexapeptidyl phosphonate inhibitor, 4 while in the heptapetide, Ser was incorporated at the P7 position in accordance with the natural R site sequence.
Kinetic analysis of the peptide substrates ( 
Ordering of unstructured regions of KSHV protease
The crystal structure of the KSHV protease complexed with a hexapeptide transition state analogue was determined at a resolution of 1.7 Å (Figure 1(b) ). The overall fold of the KSHV proteaseinhibitor structure is similar to the reported apo protease structure 18 ( Figure 1(b) ). However, several previously disordered regions are present in our structure accounting for new secondary structure elements, namely, three loops and five helices (Figure 1(c) ). The ordered loops L0a, L0b and L9 encompass the following residues: 15-20, 24-26, and 125-129, respectively. To preserve previous helix nomenclature we have kept the same numbering for the helices and we introduce a letter following the already assigned corresponding helix number to annotate new helices. Also, we annotated a small helix encompassing residues 88-91 that was left out from the nomenclature in the previous structure of apo KSHV protease. Thus, we define helices as follows: α0, residues 21-23; α0a, residues 27-33; α1, residues 74-84; α1a, residues 88-91; α2, residues 100-110; α2a, residues 120-124; α3, residues 154-159; α4, residues 166-179; α4a, residues 181-183; α5, residues 193-20; and α6, residues 209-220.
Newly ordered regions (Figure 1(c) ) encompass residues involved in substrate binding that belong to the extended substrate binding pockets. The helix 2a residues Pro120, Arg121 and Glu122 contribute to the formation of the P3, P5 and P6 binding pockets Table 1 . Hydrolysis rates of the extended substrates for KSHV protease 3, 19, 20 These structures were quite informative and compelled us to determine a highresolution structure of KSHV protease complexed with a peptide transition state analogue that contained a peptide sequence optimized for substrate binding. To design an optimal peptide sequence for this inhibitor we incorporated data from our substrate specificity profile of KSHV protease together with its natural R site sequence. 4 t-Butyl glycine, as opposed to the endogenously occurring valine, was incorporated into the substrate at P3 to increase the k cat /K M (unpublished results) as has been reported for HCMV Pr as well. 21 The atomic details of interactions of both phosphonate and peptide moieties of the inhibitor with the protease are revealed in the structure. The phosphonate group of the tetrahedral intermediate is covalently bound to the catalytic Ser114 and is further stabilized by a hydrogen bond to the Nε 2 nitrogen of His46. The electron density surrounding the phosphonate group shows that the inhibitor exists in an "aged" form, corresponding to the release of the phenoxy groups. The presence of the aged complex was expected due to the slow crystallization time of the complex. 22 The phosphonate O1B occupies the oxyanion hole and is held in place by hydrogen bonds to the main-chain amide of Arg142 and water 16. A water molecule occupying an equivalent position has been described in previous structures of herpesvirus proteases. 20, [23] [24] [25] [26] [27] This water molecule is further stabilized by a hydrogen bond to Thr146 O γ1 , the backbone amide of Arg143, and to the carbonyl oxygen of Leu113. The side-chain guanidino group of Arg142 further stabilizes the carbonyl oxygen of the P2 Gln residue, which is consistent with HCMV protease structures complexed with peptidomimetic inhibitors. 3, 19, 20 The peptide moiety of the inhibitor is bound in an extended β-strand conformation, in agreement with reported structures of shorter peptides in complex with other herpesvirus proteases 3, 19, 20, 28 (Figure 2(a) ). In the peptide moiety of the inhibitor, all residues make both hydrogen bonds and hydrophobic contacts with the protease. The backbone atoms of the residues P2-P4 form four hydrogen bonds with the backbone atoms of the protease β-strand encompassing residues 113-120, which includes the catalytic Ser114 (Figure 2(b) ). The side-chains of P2 Gln and P4 Tyr make additional hydrogen bonds with the protease interacting with Glu133 (through a water molecule) and Pro130, respectively. Pro at P6 is stabilized by four hydrophobic contacts formed via its side-chain atoms. These additional interactions may contribute to the improved binding affinity (lower K M ) that we observe for the longest heptapeptide substrate.
Induced fit in the extended substrate binding pocket
Previous structures of herpesvirus proteases suggested that conformational changes occur in the substrate binding sites upon binding of an inhibitor. 3, 20, 26, 29 With the optimized peptide inhibitor of KSHV protease we were able to assess the capacity of the enzyme to accommodate its substrates through induced conformational rearrangements. In KSHV protease, the observed induced fit 30 encompasses both small changes at the active site with movement of the side-chains of Arg142 and Arg143 as well as more dramatic rearrangements of the residues in the extended substrate binding pockets (Figure 3(b) ).
A shallow S2 site, compared to other pockets, corresponds to lower protease selectivity at the P2 position due to the smaller buried surface area upon substrate binding. Similarly, the pockets for P5 and P6 residues are very shallow. In contrast to HCMV protease, the S3 site appears to be well defined as a deep and narrow hydrophobic pocket designed to accommodate amino acids no larger than valine. Indeed, this protease has a strong in vitro preference for Val and somewhat less for Ile at this position, , the extended substrate binding sites (S1, orange; S2, slate; S3, deepblue; S4, green; S5, salmon; and S6, purple) are ordered and a deep cavity is induced in the S3 and S4 sites. Stick models in boxes represent the residues in corresponding S3-S6 binding sites that either undergo conformational changes or are ordered upon inhibitor binding.
although both protease natural substrate sequence sites R and M have Leu at this position.
The most remarkable finding is the shape of the S4 site. A deep pocket is induced upon inhibitor binding to accommodate a large Tyr residue (Figure 3(b) ), which buries 104 Å 2 . Moreover, it reveals the molecular basis of the previously reported strong preference for the large hydrophobic residues (Tyr, Trp, and Phe) at position P4. 4 The conformational change induced by the transition state analog involves residues in loop 9 (residues 125-133) (Figure 3(b) ). The side-chain amide of Gln133 moves 4.3 Å to allow binding of P4 Tyr, while Pro130 nitrogen moves 4.6 Å to accommodate binding of the Tyr hydroxyl group.
Previously disordered regions in the extended binding sites are present in our structure and in addition to S4, provide a complete description of the S3, S5 and S6 sub-sites (Figure 3(b) ). The S3 site is mostly formed by residues in the new helix 0, Gln22 and Leu23 and is further delineated by Leu25, His119 and Pro120. Compared to the apo KSHV structure, the S3 site is also formed by an induced fit, revealed by a 4.66 Å shift in the position of His119 C δ and a 3.73 Å shift for Pro120 N. The shallow S5 site is formed by His119 and newly determined helix 2a residues Arg121 and Glu122. Inhibitor binding also induces ordering of two residues that form the S6 site, Ser128 and Gly129. Our structure suggests that KSHV protease can accommodate binding of substrates up to P6, and for the longer substrate presumably the P7 amino acid may contact the protease. Kinetic data are consistent with the ordering of the P7 binding site showing a 1.8-fold improvement in K M of the Ser-Pro-Val-Tyr-tbutyl-Gln-Ala heptapeptide compared to the Pro-Val-Tyr-tbutyl-Gln-Ala hexapeptide substrate.
Conformational changes occur at the active site and dimer interface which stabilize the dimer Efficient proteolysis requires stabilization of the tetrahedral intermediate. This is partially accomplished in the herpesvirus protease by Arg142 and Arg143 stabilization of the oxyanion in the tetrahedral intermediate. Binding in the oxyanion hole appears to be sufficient for protease activation and dimer stabilization as phosphonylation of the catalytic serine by both diisopropyl fluorophosphonate (DFP) and peptidyl phosphonate inhibitors are known to stabilize the dimeric form of KSHV and Epstein-Barr virus (EBV) proteases. 4, 26 However, based on the EBV protease structure inhibited with DFP, 26 phosphonylation alone is incapable of inducing the conformational changes that we observe at the extended substrate binding sites.
Our structure reveals that binding of the peptide phosphonate inhibitor induces dimer stabilization through the network of interactions established by induced conformational changes both at the active site and the dimer interface (Figure 4(a) ). Structural changes at the active site involve residues Arg142 and Arg143 in the oxyanion hole loop L10, which undergo conformational changes to stabilize the oxyanion hole. In contrast to other herpesvirus proteases a striking conformational change occurs in the side chain of Arg143 to further support the formation of the oxyanion hole by interaction with residues in the newly formed helix 0. The sidechain guanidino group of Arg143 forms six hydrogen bonds, two directly to Leu23 in the helix 0 and the rest indirectly through three water molecules to Val11, Glu22, Leu115, and Ser117. This dense network of interactions explains why this residue is strongly conserved and why its mutation to Ala in HCMV protease reduces protease activity by 1500-fold. 31 In addition, the side-chain of Arg142 rearranges to interact with Gln22 from the same helix. This fixed conformation of the oxyanion hole loop in turn provides a rigid scaffold to stabilize helix 6 through a salt bridge between Arg144 and Asp216. Moreover, our structure reveals additional helix 6 interactions including the carbonyl oxygen of Val219 (helix 6) and His63 N ε2 , which is further stabilized by an indirect hydrogen bond interaction to the side-chain hydroxyl group of Ser15. We hypothesize that interaction of the oxyanion hole loop and helix 0 positions the loop L0a in close proximity to helix 6 to support movement of His63 (3.5 Å measured from the center of the side-chain imidazole), which stabilizes helix 6. The stabilized helix 6 is thought to be important for stabilization of helix 5 at the dimer interface. 5 Binding of the peptide phosphonate inhibitor at the active site also induces a significant conformational change at the KSHV protease dimer interface. The structure reveals unwinding of a single turn of helix 1a whose residues undergo a major conformational change to establish additional interactions at the dimer interface with an adjacent monomer's helix 6 (Figure 4 
Discussion
KSHV protease exhibits multiple levels of regulation and is a highly unique serine protease To achieve controlled spatial and temporal activation of protease activity, the herpesvirus family has evolved a unique mechanism of oligomerization and substrate-dependent regulation of enzyme activity. This mechanism requires acquisition of quaternary structure and multiple conformational changes in protease tertiary structure prior to activation. Our current model depicted in Figure 5 consists of the following steps: (i) concentration dependent dimerization leads to induced protease structure through folding of helices 5 and 6; (ii) subsequent positioning of the oxyanion hole loop required for catalysis; (iii) a substrate induced conformational change in the substrate binding pocket; and (iv) substrate induced improvement in catalytic efficiency. Here we have used crystallography and kinetic studies to obtain a snapshot of the inhibitor stabilized quaternary structure of a herpesvirus protease. Furthermore, we have provided structural evidence for extended substrate specificity for a herpesvirus protease and induced fit for substrate binding particularly at the S4 site.
Compared to classic serine proteases such as trypsin the catalytic efficiency of a herpesvirus protease is several orders of magnitude lower. 32 Available structures of trypsin provide evidence for substrate specificity in predefined sub-sites, particularly at S1 and somewhat less for S2 and S3. [32] [33] [34] In contrast, herpesvirus proteases have shallow substrate binding pockets. The decreased substrate binding affinity in KSHV protease is offset by extended substrate specificity reflected by a 20-fold decrease in K M between the tretrameric and heptameric substrate. Similarly, it has been reported for herpes simplex virus and EBV proteases that when comparing hydrolysis rates of peptides, whose prime side were fixed and non-prime sides varied, P9-P8′ and P10-P19′ substrates are cleaved with higher efficiency than substrates with only four residues at the N-terminal side. 14, 35 Our data suggest that the binding energy of an extended peptide substrate is sufficient to improve K M values for KSHV protease. In contrast, the proteolytic activity of trypsin increases dramatically (N10 4 -fold) when the length of the non-prime side of the synthetic peptides is moderately increased from P1-P'4 to P4-P'4. 36 In this case, the increase in k cat is more pronounced than the decrease in K M. In canonical serine proteases, which bind substrates in a lock and key fashion using pre-formed sub-sites, the longer substrates appear to have a more favorable conformation and undergo acylation more readily, which is reflected in the increased turnover rate. 32 On the other hand in herpesvirus proteases, substrate binding requires formation of the binding sites through an induced fit and, hence, they require extended substrates to achieve specificity and increase substrate affinity for efficient proteolysis.
Substrate induced fit can be used to sequentially regulate protease activity Structural flexibility of a macromolecule offers a simple and effective way for the regulation of enzyme activity. Factor D is another example of a serine protease whose extremely restricted proteolytic activity, in the alternate complement pathway, is regulated by a substrate induced reversible transition from its zymogen-like form to the corresponding catalytically active protease. 37, 38 Binding of its natural substrate, C3b-bound factor B, induces conformational rearrangements to form an active catalytic triad conformation. In the herpesvirus protease family, activation is regulated by a concentration dependent dimerization that induces conformational changes at the active site to form an oxyanion hole, but not the catalytic triad. Substrate or inhibitor binding then provides additional stabilization of the oxyanion hole. This is supported by the ability of a peptidomimetic inhibitor to induce the ordering of the oxyanion hole loop in an HCMV dimer interface mutant. 3 Herpesvirus proteases show further structural flexibility to accommodate binding of their substrates. Our structure reveals atomic details of the substrate-induced fit in the extended sub-sites. In addition, the reported structure of the EBV protease complexed to DFP 26 has all the secondary structure elements described in our structure and allows us to directly compare the effects of the phosphonate and the peptide moieties on the induced fit. Both DFP and the hexapapetide phosphonate inhibitor are capable of inducing changes in the active site to stabilize the oxyanion loop. However, when the hexapeptide phosphonate inhibitor is modeled on the DFP complexed structure of EVB protease, the S3 substrate-binding site is open and not formed. Similarly, P4 Tyr is completely buried in the surface of the modeled EBV structure. This suggests that sub-sites S3 and S4 are induced by the binding of the peptide moiety of the inhibitor and not the phosphonate group.
Why did herpesvirus proteases evolve such a mechanism for substrate recognition and binding? The in vivo role of the protease in capsid assembly and maturation is to process assembly protein at the M and R sites. One of the two genes that encode the assembly protein is transcribed into a larger mRNA encoding for both the protease and assembly protein. Different expression levels result in a tenfold difference between the protease and its assembly protein substrate. It has been estimated that the total protease concentration in the immature capsids is about 100 μM, 5 which would correspond to the substrate concentration for protease autoprocessing at the R site. This concentration is on the order of K M for the tetrapeptide substrate (80(±9) μM).
For efficient processing, substrate concentrations have to be several folds higher than the K M . To overcome the problem of low substrate concentration, the herpesvirus protease appears to have employed extended substrate specificity to lower the K M and improve the catalytic efficiency for autoprocessing at the R-site. In addition, the only strongly conserved residue in amino acid sequences of natural R sites across the herpesvirus protease family is Tyr at P4. Our structure reveals that binding of Tyr buries 104 Å 2 surface area that contributes 2.1 kcal/mol of binding energy. It has been shown that in vitro processing of the HCMV protease R-site peptides is 16 times slower than that of the M-site peptide and that P4 substitution of Val to Tyr in the M site sequence results in a 45% enhancement of the cleavage rate. 28 In agreement with substrate profiling data our structure shows that the enzyme can easily accommodate Tyr at P4. The strict conservation of Tyr at P4 at the R but not the M cleavage site may reflect another level of regulation and substrate differentiation. Recently it has been reported that HCMV protease fused to the assembly protein is active in the presence of a dimerization inducing kosmotrope. 11 However, an earlier study on an EVB protease that included the R-site and only four additional amino acids of the assembly protein reported that the resultant protease was inactive. 26 Altogether, these results suggest a model where the protease fused to the intact assembly protein is able to dimerize at the capsid scaffold at high concentrations and preferentially process assembly protein at the M-site, prior to release by cleavage at the R-site. Clearly both substrate specificity and the conformation of assembly protein appear to have a role in the regulation of substrate processing and ultimately viral assembly. Such a highly regulated process provides unique opportunities for intervention at the therapeutic level.
Conclusions and implications
The herpesvirus proteases initially use dimerization as the activity on/off switch and then substrate induced fit to further finely control the catalytic efficiency. The dependence of the enzyme on using conformational flexibility to regulate its activity at multiple steps provides an opportunity to design a new generation of drugs for treatment of diseases caused by herpesviruses. Since the viral assembly process is exquisitely timed and proper proteolytic activity is essential, a small perturbation of the enzyme activity can result in catastrophic effects in 
Materials and Methods
Recombinant expression and purification of KSHV Pr
A protease variant S204G resistant to autolysis was recombinantly expressed in Escherichia coli and purified as described. 39 Purified protease was stored in assay buffer (25 mM potassium phosphate (pH 8.0), 150 mM KCl, 100 μM EDTA, 1 mM β-mercaptoethanol).
Crystallization
Purified KSHV protease (26 μM) was incubated with Ac-Pro-Val-Tyr-tbut-Gln-Ala-P(OPh) 2 (50 μM) 4 for 24 h at room temperature, followed by one more addition of the same inhibitor (50 μM) and incubated for an additional 48 h. Following complete inhibition, the protease complex was purified over a Superdex-75 column and concentrated to 5.2 mg/ml in assay buffer. Crystallization was performed using the hanging drop method against: 0.8 M sodium formate, 0.1 M sodium acetate, 5% (w/v) PEG 3350. Crystals grew over the course of one to two months at 20°C as either small plates or rods dimensions 0.3 mm × 0.05 mm × 0.05 mm. Rod-shaped crystals contained one dimer in the asymmetric unit with space group P2 1 .
Data collection and refinement A 1.73 Å data set was collected at the Advance Light Source at the Berkeley National Laboratory, beamline 8.3.1. using a crystal flash cooled to 100 K in mother liquor with 20%(v/v) glycerol as the cryo-protectant. Diffraction data was integrated using Mosflm 40 and scaled and merged using SCALA. 41 The structure was solved by molecular replacement using MOLREP 42 with the apo KSHV protease structure as the search model (PDB code 1FL1 18 ). Manual cycles of rebuilding were performed using the Coot graphical interface, 43 followed by the refinement in Refmac5. 44 In the final rounds of refinement four TLS 45 groups were defined one each per protein monomer and one each per inhibitor and refined in Refmac5. 44 Our current model of KSHV protease dimer in complex with phosphonate inhibitor contains the complete sequence (3-230 amino acid residues) in molecule A, while in molecule B amino acid residue 126 is disordered. The crystallographic information is summarized in Table 2 .
Protein Data Bank accession code
The structure coordinates are deposited in the RCSB Protein Data Bank under the code 2PBK.
Solvent accessible surface area and ΔG calculation
The buried solvent accessible surface area at the substrate binding pockets was calculated using the protein interfaces, surfaces and assemblies service PISA at European Bioinformatics Institute ‡, authored by E. Krissinel & K. Henrick. 46 The difference in Gibbs free energy (ΔΔG) was calculated with the assumption that burial of 1 Å 2 of solvent accessible hydrophobic surface contributes 16 cal/mol binding energy. 47 The ΔΔG was calculated from k cat /K M values using the following formula:
where A is a longer substrate (hexapeptide) and B a shorter substrate (tetrapeptide).
Synthesis and kinetic analysis of peptide substrates
Individual peptide 7-amino-4-carbamoyl-methylcoumarin (ACC) substrates: P3-P1 (Ac-tbut-Gln-Ala-ACC), P4-P1 (Ac-Y-tbut-Gln-Ala-ACC), P5-P1-ACC (Ac-V-Ytbut-Gln-Ala-ACC), P6-P1-ACC (Ac-P-V-Y-tbut-Gln-Ala-ACC), P7-P1-ACC (Ac-S-P-V-Y-tbut-Gln-Ala-ACC) were synthesized and purified as described. 49 Concentrated KSHV protease was diluted to 1 μM and incubated at 30°C for 1 h until monomer-dimer equilibrium was established. The 98 μl of 1 μM KSHV protease were aliquoted in individual wells on a 96 well plate. Peptide stocks were prepared in dimethyl sulfoxide (DMSO) (0.6 mM-30 mM) and 2 μl were aliquoted in the protease containing wells to a final substrate concentration 6 mM-300 μM. Reaction rate of substrate hydrolysis was monitored as an increase in fluorescence of the ACC leaving group for 60 min at 30°C as described. 4 
